| human | Q5 |
| P496 | ORCID iD | 0000-0002-7669-9159 |
| P108 | employer | University of Tübingen | Q153978 |
| P735 | given name | Karin | Q1814118 |
| Karin | Q1814118 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q100640109 | Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation |
| Q35589175 | Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia |
| Q35757981 | Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation |
| Q91111301 | Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies |
| Q40309090 | Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation. |
| Q40269737 | Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients |
| Q36212750 | Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma |
| Q41579442 | Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation. |
| Q41581318 | Phagocytic activity of monocytes, their subpopulations and granulocytes during post-transplant adverse events after hematopoietic stem cell transplantation. |
| Q40413232 | Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation |
| Q40517272 | Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia. |
Search more.